OUTCOME OF SALVAGE CHEMOTHERAPY FOLLOWED BY STEM CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA IN CHILDREN-A SINGLE CENTRE EXPERIENCE

被引:0
|
作者
Panda, S. [1 ]
Narula, G. [1 ]
Gupta, A. [2 ]
Rajamanickam, D. [2 ]
Gokarn, A. [2 ]
Punatar, S. [2 ]
Mathew, L. J. [3 ]
Bagal, B. [3 ]
Arora, B. [1 ]
Khattry, N. [3 ]
Banavali, S. [2 ]
机构
[1] Tata Mem Hosp, Pediat Oncol, Bombay 400012, Maharashtra, India
[2] Tata Mem Hosp, Med Oncol, Bombay 400012, Maharashtra, India
[3] Tata Mem Hosp, Stem Cell Transplantat, Bombay 400012, Maharashtra, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O-010
引用
收藏
页码:S147 / S147
页数:1
相关论文
共 50 条
  • [31] Patients with Relapsed/Refractory Large Cell Lymphoma Who Were Also Refractory to Salvage Chemotherapy: Outcome with Salvage Radiation Therapy Followed by Autologous Stem Cell Transplant
    Yang, J. C.
    Chau, K.
    Scordo, M.
    Sauter, C. S.
    Yahalom, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S125 - S125
  • [32] Definitive salvage chemotherapy for the treatment of refractory/relapsed non-Hodgkin lymphoma, a single center experience
    Hafez, Rania
    Hussein, Safinaz
    Ismail, Marwa
    ALEXANDRIA JOURNAL OF MEDICINE, 2018, 54 (04) : 679 - 683
  • [33] Definitive Salvage Chemotherapy for the Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma, A Single Center Experience
    Hafez, Rania
    Hussein, Safinaz
    Abdelgawad, Marwa
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S247 - S247
  • [34] Prognostic Significance of PET Imaging in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Salvage Chemotherapy and Autologous Stem Cell Transplantation
    Smeltzer, Jacob
    Cashen, Amanda F.
    Zhang, Qin
    Abboud, Camille N.
    DiPersio, John F.
    Stockerl-Goldstein, Keith
    Uy, Geoffrey L.
    Vij, Ravi
    Westervelt, Peter
    Bartlett, Nancy L.
    Fehniger, Todd A.
    BLOOD, 2009, 114 (22) : 1327 - 1327
  • [35] Autologous stem cell transplantation for children and adolescents with relapsed and refractory Hodgkin's lymphoma
    Asl, A. Hedayati
    Mehrvar, A.
    Zangooei, R.
    Faranoush, M.
    Dinarooni, P.
    Olad, E.
    Jenabzadeh, M.
    Athari, G.
    Fallah, V
    Haghighi, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S277 - S277
  • [36] Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma
    Damlaj, Moussab
    Alaskar, Ahmed
    Alahmari, Bader
    Ghazi, Samer
    Hejazi, Ayman
    Alzahrani, Mohsen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S233 - S233
  • [37] THE PROGNOSTIC FACTORS EFFECTING STEM CELL TRANSPLANTATION IN CHILDREN WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA
    Atas, E.
    Kesik, V.
    Babacan, O.
    Korkmazer, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S499 - S499
  • [38] Autologous stem cell transplantation for children and adolescents with relapsed and refractory Hodgkin's lymphoma
    Hedayati-Asl, A. A.
    Mehrvar, A.
    Faranoush, M.
    Dinarooni, P.
    Zangooei, R.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S602 - S602
  • [39] ESHAP as salvage followed by BEAM as high-dose chemotherapy and autologous stem cell transplant for relapsed or refractory diffuse large cell non-Hodgkin lymphoma. A single-centre experience of 63 patients
    Akhtar, S.
    Al-Zahrani, A.
    Rahal, M.
    El Weshi, A.
    Bazarbashi, S.
    Ajarim, D.
    Khafaga, Y.
    Maghfoor, I.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S150 - S150
  • [40] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: Prognostic features and outcomes
    Engelhardt, Brian G.
    Holland, Derek W.
    Brandt, Stephen J.
    Chinratanalab, Wichai
    Goodman, Stacey A.
    Greer, John P.
    Jagasia, Madan H.
    Kassim, Adetola A.
    Morgan, David S.
    Ruffner, Katherine L.
    Schuening, Friedrich G.
    Wolff, Steven
    Bitting, Rhonda
    Sulur, Paulgun
    Stein, Richard S.
    LEUKEMIA & LYMPHOMA, 2007, 48 (09) : 1728 - 1735